Also similar to human AD [27–29], the PS19 mice exhibited elevated brain tau, thinning of the hippocampal neuronal cell layers, decreased mossy fiber synaptophysin staining, and elevated glial activation, all of which were improved with PDDC. Here, SYP is linked to Alzheimer disease.